As Professor Paul Workman steps down as Chief Executive of The Institute of Cancer Research, London, colleagues from the ICR and beyond share memories of and reflections on his impact in cancer research.

Professor Paul Workman steps down as Chief Executive of The Institute of Cancer Research. Here, we look back at a selection of the many ICR achievements during his leadership.

In the UK, sarcoma diagnoses make up more than 1% of all cancer cases. But sarcomas are hard to understand and treat, and outcomes for patients with advanced disease remain poor – they are cancers of urgent unmet need. Sarcomas are a major focus for our scientists, who are forging new collaborations and opening up fresh avenues for research and treatment.